Biospring Partners

Cellistic announces successful?certification of its GMP facility dedicated to iPSC-based cell therapies.

Please join Jeremy J. Heer, CFA, CAIA, Brad Demicco, Michael Stack, CFA, and Michelle Detwiler to discuss portfolio construction for Pensions, Endowments & Foundations and Family Offices on Wednesday, December 11th from 2:00pm-2:45pm ET. Register here: https://bit.ly/3Of26e4

Biospring Partners welcomes our new Associate, Matt McBryan. Welcome to the team, Matt!

Biospring Partners is excited to support Cedar Health Research and their CEO, Mimi Fenton, M.P.H., Ph.D in their mission of creating the leading community-focused clinical trial site network. The company has built a technology-enabled platform that allows them to provide better access to clinical trials and increase the diversity of representation in clinical research. We are thrilled to welcome them to the portfolio!

Matthew Walsh, General Manager of Biopharma at ixlayer, sat down with #FiercePharma at #DigitalPharmaEast to discuss the exciting rise of direct-to-patient (DTP) services. With over 50% of pharmaceutical marketing executives planning to implement these services, Walsh sheds light on how this shift will revolutionize the way patients interact with healthcare and, critically, simplify the patient journey. #healthcareinnovations #pharmamarketing #directtopatient https://lnkd.in/ePafpHYA

Thank you,?Eduardo Park?&?With Intelligence,?for hosting a great discussion on emerging managers in private equity. Michelle Detwiler LACERS

The University of California transforms life science research procurement with Labviva, across ten campuses

ixlayer launches 'ixEngage' a direct-to-patient platform for #biopharma

Scientists are making significant progress in bioengineering cells, giving them entirely new functionalities. This holds immense potential for developing novel medical treatments, such as creating cells that can detect and eradicate cancer. Stanford University School of Medicine #Bioegineering https://lnkd.in/e6w3d-PC

The field of synthetic immunology is offering a new approach to combating diseases. Unlike traditional immunology, which focuses on understanding the body's natural immune system, synthetic immunology builds immune systems from molecular building blocks, enhancing their capabilities to fight disease. SynBioBeta #synbio https://lnkd.in/eQxSgqJb